WallStSmart

Medtronic PLC (MDT)vsSS Innovations International Inc. Common Stock (SSII)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 98285% more annual revenue ($35.48B vs $36.07M). MDT leads profitability with a 13.0% profit margin vs -32.1%. MDT earns a higher WallStSmart Score of 56/100 (C).

MDT

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 7.3Quality: 5.0

SSII

Avoid

22

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: -0.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MDTSignificantly Overvalued (-255.7%)

Margin of Safety

-255.7%

Fair Value

$24.34

Current Price

$87.89

$63.55 premium

UndervaluedFair: $24.34Overvalued

Intrinsic value data unavailable for SSII.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$110.62B9/10

Large-cap with strong market position

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

SSII1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
192.5%10/10

Revenue surging 192.5% year-over-year

Areas to Watch

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

SSII4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.07B3/10

Smaller company, higher risk/reward

Price/BookValuation
23.1x2/10

Trading at 23.1x book value

Return on EquityProfitability
-43.4%2/10

ROE of -43.4% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin.

Bull Case : SSII

The strongest argument for SSII centers on Revenue Growth. Revenue growth of 192.5% demonstrates continued momentum.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Bear Case : SSII

The primary concerns for SSII are EPS Growth, Market Cap, Price/Book.

Key Dynamics to Monitor

MDT profiles as a value stock while SSII is a hypergrowth play — different risk/reward profiles.

SSII carries more volatility with a beta of 1.48 — expect wider price swings.

SSII is growing revenue faster at 192.5% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (56/100 vs 22/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

SS Innovations International Inc. Common Stock

HEALTHCARE · MEDICAL DEVICES · USA

SS Innovations International, Inc., is a commercial-stage surgical robotics company in India and internationally. The company is headquartered in Gurugram, India.

Visit Website →

Want to dig deeper into these stocks?